Figure 1. Key considerations for antivenom development. The development of new types of antivenom products requires careful consideration of key characteristics, including high efficacy, favorable safety profiles, and affordability. These critical aspects should be addressed throughout the product development process, starting from conception and extending to manufacturing. Comprehensive clinical assessments and rigorous approval processes are indispensable to ensure the efficacy and safety of antivenom products. Simultaneously, cost-effectiveness plays a pivotal role in ensuring the accessibility of antivenoms in regions where they are needed. It is thus essential to have the end product in mind when developing new types of antivenom products, as well as to have a holistic overview of the process. The figure was created with BioRender.com.